Ascendis Pharma A/S (asnd 2.25 04/01/28)

13F holders, Q1 2026 (March 31)
8holders +1
2new positions
1sold out
$1.63avg. 13F price*

At the end of Q1 2026, 8 institutions reported holding Ascendis Pharma A/S (asnd 2.25 04/01/28) in their 13F filings, up 1 from Q4 2025. 2 opened new positions and 1 sold out. The largest holders were Ssi Investment Management LLC ($15.9M), Polar Capital Holdings Plc ($5.1M) and Balyasny Asset Management L.P. ($4.4M).

Company
Ascendis Pharma A/S (asnd 2.25 04/01/28)
CUSIP
04351PAD3
Latest filing quarter
Q1 2026

History

Number of 13F holders

02468 Q1 2024: 3Q1 2024Q2 2024: 3Q2 2024Q3 2024: 1Q3 2024Q4 2024: 2Q4 2024Q1 2025: 2Q1 2025Q2 2025: 3Q2 2025Q3 2025: 4Q3 2025Q4 2025: 7Q4 2025Q1 2026: 8Q1 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions2$20.3M
Exits1$279K

All 13F filers, Q4 2025 → Q1 2026: 13,838,400 shares bought and 1,701,689 shares sold, net +12,136,711 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 8 holders

Ssi Investment Management LLC 1.31% New 10,834,000 $15.9M
Polar Capital Holdings Plc 0.02% Reduce -30.0% 3,500,000 $5.1M
Balyasny Asset Management L.P. 0.01% New 3,000,000 $4.4M
State of Wisconsin Investment Board 0.01% No change 3,000,000 $4.4M
Loomis Sayles & Co. L P 0.00% Reduce -9.5% 16,027 $3.7M
BNP PARIBAS ASSET MANAGEMENT Holding S.A. 0.00% No change 2,000,000 $3.0M
Boussard & Gavaudan Investment Management LLP 0.00% Add +51.8% 12,900 $19K
Oddo BHF Asset Management Sas 0.00% No change 161 $237

"% of holder's portfolio" is ASCENDIS PHARMA A/S (ASND 2.25 04/01/28)'s weight in each manager's 13F, not the share of Ascendis Pharma A/S (asnd 2.25 04/01/28) the manager owns.